These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28941809)

  • 1. Liquid chromatography - high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control.
    Joré C; Loup B; Garcia P; Paris AC; Popot MA; Audran M; Bonnaire Y; Varlet-Marie E; Bailly-Chouriberry L
    J Chromatogr A; 2017 Oct; 1521():90-99. PubMed ID: 28941809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.
    Guan F; Uboh CE; Soma LR; Maylin G; Jiang Z; Chen J
    Anal Chem; 2010 Nov; 82(21):9074-81. PubMed ID: 20945883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of erythropoiesis-stimulating agents in a single dried blood spot.
    Reverter-Branchat G; Ventura R; Ezzel Din M; Mateus J; Pedro C; Segura J
    Drug Test Anal; 2018 Oct; 10(10):1496-1507. PubMed ID: 29877055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 5. A fast screening method for the detection of CERA in dried blood spots.
    Rocca A; Martin L; Kuuranne T; Ericsson M; Marchand A; Leuenberger N
    Drug Test Anal; 2022 May; 14(5):820-825. PubMed ID: 34380180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking main environmental factors masking a minor steroidal doping effect using metabolomic analysis of horse urine by liquid chromatography-high-resolution mass spectrometry.
    Stojiljkovic N; Leroux F; Bubanj S; Popot MA; Paris A; Tabet JC; Junot C
    Eur J Mass Spectrom (Chichester); 2019 Jun; 25(3):339-353. PubMed ID: 31096786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood.
    Reichel C; Abzieher F; Geisendorfer T
    Drug Test Anal; 2009 Nov; 1(11-12):494-504. PubMed ID: 20355164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse.
    Ho EN; Kwok WH; Lau MY; Wong AS; Lam KK; Stewart BD; Wan TS
    J Chromatogr A; 2014 Apr; 1338():92-101. PubMed ID: 24636755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of erythropoietin mimetic peptide 1 linear form in a sealed vial and its administration study in horses for doping control purpose.
    So YM; Wong JKY; Wong ASY; Tse ATL; Wan TSM; Ho ENM
    Drug Test Anal; 2024 Jan; 16(1):71-82. PubMed ID: 37248680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis-stimulating agents: development, detection and dangers.
    Franz SE
    Drug Test Anal; 2009 Jun; 1(6):245-9. PubMed ID: 20355203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
    Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
    Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator.
    Yoshida T; Hayashi M
    Keio J Med; 2017 Sep; 66(3):44-50. PubMed ID: 27990008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.